Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab

  1. Pérez de Llano, L.A.
  2. Dacal Rivas, D.
  3. Cosío, B.G.
Journal:
Allergy: European Journal of Allergy and Clinical Immunology

ISSN: 1398-9995,  0105-4538

Year of publication: 2020

Volume: 75

Issue: 4

Pages: 940-942

Type: Letter

DOI: 10.1111/ALL.14035 GOOGLE SCHOLAR
Data source: Scopus